Grunwald, Germany

Josef Wagner


Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1978-1980

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Josef Wagner

Introduction

Josef Wagner is a notable inventor based in Grunwald, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of hypolipidaemic agents. With a total of 4 patents to his name, Wagner's work has had a considerable impact on medical treatments.

Latest Patents

Wagner's latest patents include novel derivatives of 1,3-diphenoxypropane-2-on, which are recognized for their strong hypolipidaemic properties. These compounds, characterized by the formula ##STR1##, feature various substituents such as Cl, Br, CH(CH.sub.3).sub.2, or C(CH.sub.3).sub.3. Additionally, he has developed new 1,3-disubstituted propanol-(2) derivatives and their nicotinic acid esters, which are also aimed at treating hyperlipemia. These innovations highlight his commitment to advancing pharmaceutical science.

Career Highlights

Wagner is currently associated with Klinge Pharma GmbH & Co., where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the scientific community but has also paved the way for new therapeutic options for patients suffering from lipid disorders.

Collaborations

Throughout his career, Wagner has collaborated with esteemed colleagues such as Helmut Grill and Rainer Hans Zschocke. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Josef Wagner's contributions to the field of pharmaceuticals through his patents and collaborations underscore his role as a significant inventor. His work continues to influence the development of effective treatments for hyperlipemia and related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…